GreenLight Biosciences Operating Income

GreenLight Biosciences (GRNA) currently reports a operating income of $-160M as of March 2023. That compares with $-29M in the prior-year period — down 438.0% year over year. Use the charts on this page to explore GreenLight Biosciences's operating income history and peer comparisons.

GreenLight Biosciences's operating income decreased from $-29M to $-160M — a 438.0% year-over-year decrease (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GreenLight Biosciences reported $-160M in operating income as of March 2023. That compares with $-29M in the prior-year period — down 438.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-160M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GreenLight Biosciences, and consider following GRNA for alerts when major investors trade the stock.